pyridoxal phosphate has been researched along with Arteriosclerosis, Coronary in 7 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in women and the elderly are unknown." | 7.69 | Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. ( Green, R; Gupta, A; Kottke-Marchant, K; Mayer, EL; Miller, DP; Nissen, SE; Robinson, K; Savon, SR; Selhub, J; van Lente, F, 1995) |
| "Patients with at least 50% stenosis of one major coronary artery identified by cardiac catheterization were assigned to the case group (n = 45)." | 5.38 | A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease. ( Hsia, S; Hsu, HC; Lee, BJ; Lin, JY; Lin, PT; Yen, CH, 2012) |
| "High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in women and the elderly are unknown." | 3.69 | Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. ( Green, R; Gupta, A; Kottke-Marchant, K; Mayer, EL; Miller, DP; Nissen, SE; Robinson, K; Savon, SR; Selhub, J; van Lente, F, 1995) |
| "Patients with at least 50% stenosis of one major coronary artery identified by cardiac catheterization were assigned to the case group (n = 45)." | 1.38 | A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease. ( Hsia, S; Hsu, HC; Lee, BJ; Lin, JY; Lin, PT; Yen, CH, 2012) |
| "The odds ratio (OR) for severe coronary atherosclerosis (case status) for each 1 SD increase in fasting tHcy (5 micromol/L) was 1." | 1.30 | Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. ( Grobbee, DE; Kok, FJ; Kruyssen, DA; Refsum, H; Schouten, EG; Ueland, PM; Verhoef, P; Witteman, JC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulvik, A | 1 |
| Pedersen, ER | 1 |
| Svingen, GF | 1 |
| McCann, A | 1 |
| Midttun, Ø | 1 |
| Nygård, O | 1 |
| Ueland, PM | 2 |
| Lee, BJ | 1 |
| Yen, CH | 1 |
| Hsu, HC | 1 |
| Lin, JY | 1 |
| Hsia, S | 1 |
| Lin, PT | 2 |
| Friso, S | 1 |
| Girelli, D | 1 |
| Martinelli, N | 1 |
| Olivieri, O | 1 |
| Lotto, V | 1 |
| Bozzini, C | 1 |
| Pizzolo, F | 1 |
| Faccini, G | 1 |
| Beltrame, F | 1 |
| Corrocher, R | 1 |
| Dierkes, J | 1 |
| Hoffmann, K | 1 |
| Klipstein-Grobusch, K | 1 |
| Weikert, C | 1 |
| Boeing, H | 1 |
| Zyriax, BC | 1 |
| Windler, E | 1 |
| Kratzsch, J | 1 |
| Cheng, CH | 1 |
| Liaw, YP | 1 |
| Ho, CC | 1 |
| Tsai, TP | 1 |
| Chou, MC | 1 |
| Huang, YC | 1 |
| Robinson, K | 1 |
| Mayer, EL | 1 |
| Miller, DP | 1 |
| Green, R | 1 |
| van Lente, F | 1 |
| Gupta, A | 1 |
| Kottke-Marchant, K | 1 |
| Savon, SR | 1 |
| Selhub, J | 1 |
| Nissen, SE | 1 |
| Verhoef, P | 1 |
| Kok, FJ | 1 |
| Kruyssen, DA | 1 |
| Schouten, EG | 1 |
| Witteman, JC | 1 |
| Grobbee, DE | 1 |
| Refsum, H | 1 |
7 other studies available for pyridoxal phosphate and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Hum | 2016 |
A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cholesterol; Constriction, Pathologic; Coronar | 2012 |
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk.
Topics: Acute-Phase Proteins; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Artery Disease | 2004 |
Low plasma pyridoxal-5'phosphate and cardiovascular disease risk in women: results from the Coronary Risk Factors for Atherosclerosis in Women Study.
Topics: C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Humans; Inflammation; Pyr | 2005 |
Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Artery Disease; Female; Homocy | 2008 |
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.
Topics: Age Factors; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid Deficiency; Hom | 1995 |
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.
Topics: Adult; Aging; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Erythrocytes; Fem | 1997 |